Search
Professor Christopher Nutting

Professor Christopher Nutting

Clinical oncology, Medical oncology 03616743

 

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Professor Chris Nutting is one of the United Kingdom's leading clinical oncologists, internationally recognised for his expertise in the treatment of head and neck cancer and thyroid cancer. With more than 25 years of experience at the forefront of cancer care, he has built a reputation for delivering outstanding outcomes through a combination of clinical excellence, advanced technology, and a deeply patient-centred approach.

Prof Nutting trained at some of the UK's most prestigious medical institutions and is Professor in the Division of Radiotherapy and Imaging at The Institute of Cancer Research, as well as a senior Consultant Clinical Oncologist and Medical Director of Private Care at The Royal Marsden Hospital. His career has been defined by a commitment to innovation and a drive to adopt techniques that improve cure rates while minimising side effects. He was one of the earliest oncologists in Europe to champion intensity-modulated radiotherapy (IMRT) for head and neck cancers, helping establish it as a global standard of care. This work has transformed treatment tolerability and quality of life for thousands of patients.

As a world-leading authority in precision radiotherapy, Prof Nutting specialises in IMRT, image-guided radiotherapy, stereotactic radiotherapy (SRT), and proton therapy. His expertise in thyroid cancer includes both early-stage and advanced disease, with in-depth experience in complex cases requiring multidisciplinary input. He is regularly sought for second opinions from across the UK and internationally, reflecting his standing as a trusted expert in complex oncological decision-making.

Prof Nutting has authored over 350 peer-reviewed publications, contributed to international treatment guidelines, and led multiple landmark clinical trials that have shaped modern oncology. His research has directly influenced global radiotherapy standards and continues to advance the field, particularly in reducing long-term toxicity and improving functional outcomes for patients. He lectures worldwide, mentoring the next generation of oncologists and serving as an advisor to national and international cancer organisations.

Patients frequently describe Prof Nutting as exceptionally approachable, compassionate, and meticulous. He is known for taking the time to guide patients and families through every stage of diagnosis and treatment, ensuring they feel informed, supported, and empowered. His clinics are characterised by a calm, reassuring manner and a commitment to personalised care, guided by the latest evidence and tailored to each patient's needs and priorities.

He works closely within multidisciplinary teams�including surgeons, radiologists, pathologists, speech therapists, endocrinologists, and restorative specialists�to ensure that every patient receives a comprehensive and coherent treatment plan. This collaborative approach is central to his excellent outcomes and is especially valued by patients with complex head and neck or thyroid cancers.

Whether patients are seeking advanced radiotherapy, expert guidance on thyroid cancer management, or a second opinion on a challenging diagnosis, Professor Chris Nutting offers an unparalleled combination of scientific expertise, clinical experience, and compassionate care. His dedication to achieving the best possible outcomes makes him one of the most highly regarded cancer specialists in the UK today.

Areas of interest

Head and neck cancer; Mouth cancer; Neck lumps; Throat cancer; Tonsil cancer; Neck cancer; Skin cancer; Thyroid Cancer; Thyroid nodules; Thyroid lumps; Radioiodine treatment; Cyberknife; Complex radiotherapy techniques; Intensity Modulated Radiotherapy; Chemotherapy; Clinical trials; Second opinion, radiotherapy side effects, Proton beam therapy; Immunotherapy; Trials; TKI therapy

Medical secretaries

About me
About my work
My outcomes
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

  • 20365

    Follow-up out-patient consultation - remote - (5-50)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

  • 20355

    Initial out-patient consultation - remote - (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

  • Show All (6 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.